The Latest Breaking News from Cancer

Moderna Stock Soars More Than 100% on Cancer Vaccine Breakthrough: What Investors Are Betting On

Moderna shares surged after its personalised mRNA cancer treatment met key Phase 3 trial endpoints in melanoma with Merck's Keytruda.

International Business Times UK · Aug 19

Meet Audrey Zheng, the 17-year-old Pennsylvania student who developed a pancreatic cancer test; it correctly identified 87% of patients and 87.5% without the disease

A talented high school student has pioneered a cutting-edge bioengineering method for the early detection of pancreatic cancer. By utilizing magnetic beads to isolate tumor-derived particles from blood samples, her clinical trials demonstrated remarkable accuracy. Her extraordinary research has secured her a spot as a national finalist in a prestigious…

The Times of India · Aug 19

5 Zodiac signs finally see their luck turn around before August 2026 ends

The conclusion of August 2026 marks a pivotal moment for five zodiac signs. Leo's newfound confidence drives its actions, whereas Libra enjoys a streak of good luck. Cancer rises to assert its voice, and Virgo defies outside expectations. Meanwhile, Pisces feels a sense of relief as it turns the page…

The Economic Times · Aug 19

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Reason · Aug 19

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Fortune · Aug 19

A Bean Gum Wiped Out Cancer-Linked Mouth Bacteria and Left the Good Ones Alone

A Penn gum cut cancer-linked oral bacteria by more than 99 percent in patient samples while sparing protective streptococci. A trial comes next.

Medical Daily · Aug 19

This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results

Moderna stock rips higher on a major cancer breakthrough. The announcement led William Blair to upgrade MRNA shares to "Outperform."

Barchart · Aug 19

Moderna stock more than doubles after skin cancer breakthrough announcement

IN FULL

The Independent UK · Aug 19

Moderna Shares Double Overnight Because a Made-to-Order mRNA Vaccine Actually Beats Skin Cancer

Moderna's personalised mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence in a Phase 3 trial, doubling the company's stock value and marking a milestone in cancer treatment.

International Business Times UK · Aug 19

How we found a new transmissible cancer in bullhead catfish

For more than a decade, anglers on Lake Memphremagog — which straddles the Québec-Vermont border — have been catching brown bullhead catfish marked with distinctive black lesions.

The Conversation · Aug 19